Cargando…

ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance

The diverse repertoires of cellular mechanisms that progress certain cancer types are being uncovered by recent research and leading to more effective treatment options. Ovarian cancer (OC) is among the most difficult cancers to treat. OC has limited treatment options, especially for patients diagno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stieg, David C., Wang, Yifang, Liu, Ling-Zhi, Jiang, Bing-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223852/ https://www.ncbi.nlm.nih.gov/pubmed/35743145 http://dx.doi.org/10.3390/ijms23126702

Ejemplares similares

Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts
por: Yang, Fengming, et al.
Publicado: (2017)

Role of miRNA dysregulation in sepsis
por: Formosa, Amanda, et al.
Publicado: (2022)

Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as Biomarkers
por: Anelli, Luisa, et al.
Publicado: (2021)

MiRNA Dysregulation in Childhood Hematological Cancer
por: Carvalho de Oliveira, Jaqueline, et al.
Publicado: (2018)

Dysregulation of lncRNA–miRNA–mRNA Interactome as a Marker of Metastatic Process in Ovarian Cancer
por: Pronina, Irina V., et al.
Publicado: (2022)

Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis
por: Jiang, Cheng-Fei, et al.
Publicado: (2016)

Roles of miRNA dysregulation in the pathogenesis of multiple myeloma
por: Chen, Dan, et al.
Publicado: (2021)

Role and Dysregulation of miRNA in Patients with Parkinson’s Disease
por: Salemi, Michele, et al.
Publicado: (2022)

Dysregulated plasma levels of miRNA-132 and miRNA-134 in patients with obsessive-compulsive disorder
por: Yue, Jihui, et al.
Publicado: (2020)

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
por: Gentile, Giulia, et al.
Publicado: (2022)

MiRNA-145 increases therapeutic sensibility to gemcitabine treatment of pancreatic adenocarcinoma cells
por: Lin, Yong, et al.
Publicado: (2016)

Identification of keygenes, miRNAs and miRNA-mRNA regulatory pathways for chemotherapy resistance in ovarian cancer
por: Wang, Wenwen, et al.
Publicado: (2021)

Temporal dynamics of miRNAs in human DLPFC and its association with miRNA dysregulation in schizophrenia
por: Hu, Zhonghua, et al.
Publicado: (2019)

The use of miRNA microarrays for the analysis of cancer samples with global miRNA decrease
por: Wu, Di, et al.
Publicado: (2013)

miRNA–mRNA–protein dysregulated network in COPD in women
por: Li, Chuan Xing, et al.
Publicado: (2022)

miRNA dysregulation in cancer: towards a mechanistic understanding
por: Palanichamy, Jayanth Kumar, et al.
Publicado: (2014)

Mechanisms Contributing to the Dysregulation of miRNA-124 in Pulmonary Hypertension
por: Zhang, Hui, et al.
Publicado: (2021)

Characterization of Adrenal miRNA-Based Dysregulations in Cushing’s Syndrome
por: Vetrivel, Sharmilee, et al.
Publicado: (2022)

The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies
por: Zhang, Zhengjia, et al.
Publicado: (2022)

Correction: Temporal dynamics of miRNAs in human DLPFC and its association with miRNA dysregulation in schizophrenia
por: Hu, Zhonghua, et al.
Publicado: (2019)

Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients
por: Ouyang, Xiaoxi, et al.
Publicado: (2016)

Integrated miRNA and mRNA expression profiling to identify mRNA targets of dysregulated miRNAs in pulmonary tuberculosis
por: Zhang, Xing, et al.
Publicado: (2018)

Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma
por: Vahabi, Mahrou, et al.
Publicado: (2023)

Obesity, Insulin Resistance, and Colorectal Cancer: Could miRNA Dysregulation Play a Role?
por: Cirillo, Francesca, et al.
Publicado: (2019)

Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma
por: Qin, Shijie, et al.
Publicado: (2021)

Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer
por: Xue, Bai, et al.
Publicado: (2021)

The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas
por: Beyer, Sasha, et al.
Publicado: (2017)

EGFL7 meets miRNA-126: an angiogenesis alliance
por: Nikolic, Iva, et al.
Publicado: (2010)

Looking into a Conceptual Framework of ROS–miRNA–Atrial Fibrillation
por: Lee, Seahyoung, et al.
Publicado: (2014)

Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival
por: Bray, Isabella, et al.
Publicado: (2009)

Integrated miRNA and mRNA expression profiling to identify mRNA targets of dysregulated miRNAs in non-obstructive azoospermia
por: Zhuang, Xuan, et al.
Publicado: (2015)

Risk miRNA screening of ovarian cancer based on miRNA functional synergistic network
por: Ying, Huanchun, et al.
Publicado: (2014)

miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer
por: Kousar, Kousain, et al.
Publicado: (2022)

miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives
por: Sessa, Francesco, et al.
Publicado: (2023)

The Role of miRNA in Ovarian Cancer: an Overview
por: Zhao, Lihui, et al.
Publicado: (2022)

Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer
por: Wong, Jun Sheng, et al.
Publicado: (2020)

MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma
por: Otoukesh, Babak, et al.
Publicado: (2020)

Identification of targets of miRNA-221 and miRNA-222 in fulvestrant-resistant breast cancer
por: Liu, Pengfei, et al.
Publicado: (2016)

Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer
por: White, N M A, et al.
Publicado: (2010)

Digesting dietary miRNA therapeutics
por: Yarmarkovich, Mark, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_59mokhl9sfn7mo8l88n875n39j